维普期刊资源整合服务平台（V6.5）

146篇 您的检索式：作者名="DAMAS JK"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Systemic inflammation in heart failure- the why and wherefores 显示文摘	Yndestad A Damas JK Qie E	2006	Heart Fail Rev2006，11，1：	1
2	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，：	1
3	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCI2 显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，6：	1
4	Systemic inflammation inheart failure-the whys and wherefores显示文摘	Yndestad A Damas JK Oie E	2006	Heart Fail Rev2006，11，1：	1
5	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCI2显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，6：	1
6	CXC-chemokines, a new group of cytokines in congestive heart failure-possible role of platelets and monocytes显示文摘	Damas JK Gullestad L Ueland T	2000	Cardiovasc Res2000，45，：	1
7	Systemic inflamma- tion in heart failure the whys and wherefores显示文摘	YNDESTAD A DAMAS JK OIE E	2006	Heart Fail Rev2006，11，1：	1
8	Inflammatory role of platelets in acute coronary syndromes显示文摘	Aukrust P Waehre T Damas JK	2001	Heart2001，86，6：	1
9	Increased expression of fractalkine ( CX3CL1 ) and its receptor, CX3CR1, in Wegener's granulomatosis-possible role in vascular inflammation 显示文摘	Bjerkeli V Damas JK Fevang B	2007	Rheumatology2007，46，9：	1
10	Agents targeting inflammation in heart failure显示文摘	Gullestad L Kjekshus J Damas JK	2005	Expert Opin Investig Drugs2005，14，5：	1
11	Cytokines as new treatment targets in chronic heart failure显示文摘	Damas JK Gullestad L Aukrust P	2001	Curr Control Trials Cardiovasc Med2001，2，：	1
12	Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure显示文摘	Damas JK Eiken HG Oie E	2000	Cardiovasc Res2000，47，：	1
13	Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10显示文摘	Waehre T Halvorsen B Damas JK et ol	2002	Eur J Clin Invest2002，32，：	1
14	Expression of Fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery, disease and is reduced during statin therapy 显示文摘	Damas JK Boullier A W?hre T	2005	Arterioscler Thromb Vasc Biol2005，25，：	1
15	Systemic intlammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 显示文摘	Haukelandl JW Dama JK Konopski Z	2006	J Hepatol2006，44，：	1
16	Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes possible role of platelet-mediated vascular inflammation显示文摘	Smith C Damas JK Otterdal K	2006	J Am Coll Cardiol2006，48，8：	1
17	Therapeutic potential of anticytokine therapy in congestive heart failure显示文摘	Yndestad A Damas JK	2004	Am J Cardiovasc Drugs2004，4，：	1
18	Chemokines in myocardial failure pathogenic importance and potential therapeutic targets显示文摘	Aukrust P Damas JK Gullestad L	2001	Clin Exp Immunol2001，124，3：	1
19	Myocardial expression of CC -and CXC -chemokines and their receptors in human end -stage heart failure 显示文摘	Damas JK Eiken HG Oie E	2000	Cardiovase Res2000，47，4：	1
20	Systemic inflammation in heart failure--the whys and wherefores显示文摘	Yndestad A Damas JK Qie E	2006	Heart Fail Rev2006，11，1：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示